Propranolol use and survival from breast cancer: A pooled analysis of 133,251 breast cancer patients from the European Cancer Pharmacoepidemiology Network

Christopher Cardwell; Anton Pottegård; Evelien Vaes; Hans Garmo; Chris Brown; Pauline Vissers; Michael O'Rorke; Kala Visvanathan; D.P. Cronin-Fenton; Harlinde De Schutter; M. Lambe; Des G Powe; Myrthe P P van Herk-Sukel; Anna Gavin; Søren Friis; Linda Sharp; Kathleen Bennett

Propranolol use and survival from breast cancer: A pooled analysis of 133,251 breast cancer patients from the European Cancer Pharmacoepidemiology Network

Christopher Cardwell, Anton Pottegård, Evelien Vaes, Hans Garmo, Chris Brown, Pauline Vissers, Michael O'Rorke, Kala Visvanathan, D.P. Cronin-Fenton, Harlinde De Schutter, M. Lambe, Des G Powe, Myrthe P P van Herk-Sukel, Anna Gavin, Søren Friis, Linda Sharp, Kathleen Bennett

School of Medicine, Dentistry and Biomedical Sciences

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Publication status	Published - 26 Aug 2016
Event	32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management - Barcelona Duration: 27 Aug 2016 → …

Conference

Conference	32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management
Period	27/08/2016 → …

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Cardwell, C., Pottegård, A., Vaes, E., Garmo, H., Brown, C., Vissers, P., O'Rorke, M., Visvanathan, K., Cronin-Fenton, D. P., De Schutter, H., Lambe, M., Powe, D. G., van Herk-Sukel, M. P. P., Gavin, A., Friis, S., Sharp, L., & Bennett, K. (2016). Propranolol use and survival from breast cancer: A pooled analysis of 133,251 breast cancer patients from the European Cancer Pharmacoepidemiology Network. Abstract from 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.

@conference{33363eddc9fc43bbb10bc4737c7ebb98,

title = "Propranolol use and survival from breast cancer: A pooled analysis of 133,251 breast cancer patients from the European Cancer Pharmacoepidemiology Network",

author = "Christopher Cardwell and Anton Potteg{\aa}rd and Evelien Vaes and Hans Garmo and Chris Brown and Pauline Vissers and Michael O'Rorke and Kala Visvanathan and D.P. Cronin-Fenton and {De Schutter}, Harlinde and M. Lambe and Powe, {Des G} and {van Herk-Sukel}, {Myrthe P P} and Anna Gavin and S{\o}ren Friis and Linda Sharp and Kathleen Bennett",

year = "2016",

month = aug,

day = "26",

language = "English",

note = "32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management ; Conference date: 27-08-2016",

}

Cardwell, C, Pottegård, A, Vaes, E, Garmo, H, Brown, C, Vissers, P, O'Rorke, M, Visvanathan, K, Cronin-Fenton, DP, De Schutter, H, Lambe, M, Powe, DG, van Herk-Sukel, MPP, Gavin, A, Friis, S, Sharp, L & Bennett, K 2016, 'Propranolol use and survival from breast cancer: A pooled analysis of 133,251 breast cancer patients from the European Cancer Pharmacoepidemiology Network', 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 27/08/2016.

Propranolol use and survival from breast cancer: A pooled analysis of 133,251 breast cancer patients from the European Cancer Pharmacoepidemiology Network. / Cardwell, Christopher; Pottegård, Anton; Vaes, Evelien et al.
2016. Abstract from 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Propranolol use and survival from breast cancer: A pooled analysis of 133,251 breast cancer patients from the European Cancer Pharmacoepidemiology Network

AU - Cardwell, Christopher

AU - Pottegård, Anton

AU - Vaes, Evelien

AU - Garmo, Hans

AU - Brown, Chris

AU - Vissers, Pauline

AU - O'Rorke, Michael

AU - Visvanathan, Kala

AU - Cronin-Fenton, D.P.

AU - De Schutter, Harlinde

AU - Lambe, M.

AU - Powe, Des G

AU - van Herk-Sukel, Myrthe P P

AU - Gavin, Anna

AU - Friis, Søren

AU - Sharp, Linda

AU - Bennett, Kathleen

PY - 2016/8/26

Y1 - 2016/8/26

M3 - Abstract

T2 - 32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management

Y2 - 27 August 2016

ER -